Detalhe da pesquisa
1.
Network models to enhance the translational impact of cross-species studies.
Nat Rev Neurosci
; 24(9): 575-588, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524935
2.
Urinary tract infections trigger synucleinopathy via the innate immune response.
Acta Neuropathol
; 145(5): 541-559, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991261
3.
The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease.
Neurobiol Dis
; 168: 105687, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35283326
4.
Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease.
Neurobiol Dis
; 136: 104712, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837422
5.
Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies.
J Neurosci
; 37(24): 5870-5884, 2017 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522732
6.
Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.
Acta Neuropathol
; 131(4): 621-37, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26659577
7.
A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs.
NPJ Parkinsons Dis
; 10(1): 65, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504090
8.
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology.
Nat Commun
; 15(1): 2642, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531900
9.
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression.
Transl Neurodegener
; 13(1): 13, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438877
10.
Glucose sensitivity of mouse olfactory bulb neurons is conveyed by a voltage-gated potassium channel.
J Physiol
; 591(10): 2541-61, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23478133
11.
Spatial transcriptomics reveals molecular dysfunction associated with Lewy pathology.
bioRxiv
; 2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292685
12.
A rapid microglial metabolic response controls metabolism and improves memory.
bioRxiv
; 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066282
13.
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.
NPJ Parkinsons Dis
; 9(1): 74, 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169750
14.
Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala.
Elife
; 112022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35775627
15.
A novel automated morphological analysis of Iba1+ microglia using a deep learning assisted model.
Front Cell Neurosci
; 16: 944875, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36187297
16.
LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons.
J Parkinsons Dis
; 11(3): 1187-1196, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720852
17.
Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor.
Sci Adv
; 7(24)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108219
18.
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult.
Neuron
; 105(5): 822-836.e7, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899072
19.
α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
Neurosci Lett
; 709: 134316, 2019 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170426
20.
Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease.
Acta Neuropathol Commun
; 7(1): 183, 2019 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31733655